Trichloroacetaldehyde
Star0
Identification
- Generic Name
- Trichloroacetaldehyde
- DrugBank Accession Number
- DB02650
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 147.388
Monoisotopic: 145.909297775 - Chemical Formula
- C2HCl3O
- Synonyms
- 2,2,2-trichloroacetaldehyde
- Anhydrous chloral
- Chloral
- Tri-chloro-acetaldehyde
- Trichloroacetaldehyd
- Trichloroethanal
- External IDs
- UN2075
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as organochlorides. These are compounds containing a chemical bond between a carbon atom and a chlorine atom.
- Kingdom
- Organic compounds
- Super Class
- Organohalogen compounds
- Class
- Organochlorides
- Sub Class
- Not Available
- Direct Parent
- Organochlorides
- Alternative Parents
- Organic oxides / Hydrocarbon derivatives / Alkyl chlorides / Aldehydes
- Substituents
- Aldehyde / Aliphatic acyclic compound / Alkyl chloride / Alkyl halide / Carbonyl group / Hydrocarbon derivative / Organic oxide / Organic oxygen compound / Organochloride / Organooxygen compound
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- organochlorine compound, aldehyde (CHEBI:48814)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- FLI06WS32H
- CAS number
- 75-87-6
- InChI Key
- HFFLGKNGCAIQMO-UHFFFAOYSA-N
- InChI
- InChI=1S/C2HCl3O/c3-2(4,5)1-6/h1H
- IUPAC Name
- 2,2,2-trichloroacetaldehyde
- SMILES
- [H]C(=O)C(Cl)(Cl)Cl
References
- General References
- Not Available
- External Links
- KEGG Compound
- C14866
- PubChem Compound
- 6407
- PubChem Substance
- 46506955
- ChemSpider
- 13863645
- 38574
- ChEBI
- 48814
- ChEMBL
- CHEMBL27551
- ZINC
- ZINC000003875479
- PDBe Ligand
- CLX
- Wikipedia
- Chloral
- PDB Entries
- 4yas
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 3.15 mg/mL ALOGPS logP 1.38 ALOGPS logP 1.37 Chemaxon logS -1.7 ALOGPS pKa (Strongest Basic) -8 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 17.07 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 27.23 m3·mol-1 Chemaxon Polarizability 10.43 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9971 Blood Brain Barrier + 0.991 Caco-2 permeable + 0.6527 P-glycoprotein substrate Non-substrate 0.8876 P-glycoprotein inhibitor I Non-inhibitor 0.9806 P-glycoprotein inhibitor II Non-inhibitor 0.9577 Renal organic cation transporter Non-inhibitor 0.9265 CYP450 2C9 substrate Non-substrate 0.8293 CYP450 2D6 substrate Non-substrate 0.7038 CYP450 3A4 substrate Non-substrate 0.7312 CYP450 1A2 substrate Non-inhibitor 0.596 CYP450 2C9 inhibitor Non-inhibitor 0.8984 CYP450 2D6 inhibitor Non-inhibitor 0.9527 CYP450 2C19 inhibitor Non-inhibitor 0.7477 CYP450 3A4 inhibitor Non-inhibitor 0.947 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9306 Ames test AMES toxic 0.9107 Carcinogenicity Carcinogens 0.6976 Biodegradation Not ready biodegradable 0.7948 Rat acute toxicity 2.4796 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9679 hERG inhibition (predictor II) Non-inhibitor 0.9542
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 95.279526 predictedDarkChem Lite v0.1.0 [M-H]- 120.49963 predictedDeepCCS 1.0 (2019) [M+H]+ 96.247926 predictedDarkChem Lite v0.1.0 [M+H]+ 122.39505 predictedDeepCCS 1.0 (2019) [M+Na]+ 95.800526 predictedDarkChem Lite v0.1.0 [M+Na]+ 130.6619 predictedDeepCCS 1.0 (2019)
Drug created at June 13, 2005 13:24 / Updated at August 01, 2020 13:44